Catalog No.: PC-61052Not For Human Use, Lab Use Only.
hTG2 inhibitor VA4(VA4) is a novel potent, irreversible inhibitor of human tissue transglutaminase (hTG2) with Ki of 12.9 uM, allosterically abolishs its GTP binding ability with a high degree of selectivity and efficiency.
hTG2 inhibitor VA4 (VA4) is a novel potent, irreversible inhibitor of human tissue transglutaminase (hTG2) with Ki of 12.9 uM, allosterically abolishs its GTP binding ability with a high degree of selectivity and efficiency.
hTG2 inhibitor VA4 inhibits both the transamidation and GTP binding activity of hTG2 in a cellular context.
hTG2 inhibitor VA4 inhibits epidermal cancer stem cell invasion with EC50 of 3.9 uM.
